True or False: Drugs intended for in-house use must be in child resistant containers.

The correct answer is that it is false that drugs intended for in-house use must be in child-resistant containers. According to the Poison Prevention Packaging Act (PPPA), child-resistant packaging is primarily required for prescription medications and certain over-the-counter medications that pose a significant risk of poisoning to children. However, this requirement does not automatically extend to drugs that are used in-house or for institutional use when they are not intended for dispensing.

In a healthcare facility, medications may be administered under controlled conditions and are not necessarily required to be in child-resistant packaging unless they are specifically prescribed for pediatric use. Therefore, the requirement for child-resistant containers is contingent upon the nature of the medication and its intended use rather than simply being in-house.

This distinction clarifies why the statement is false; the regulation emphasizes the importance of protecting children from accidental ingestion, but it does not mandate child-resistant packaging for all medications that are used within a facility.